KRIYA 382
Alternative Names: KRIYA-382Latest Information Update: 14 Feb 2024
At a glance
- Originator Kriya Therapeutics
- Class Antiepileptic drugs; Gene therapies
- Mechanism of Action Ion channel replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Research Epilepsy